Jillian Connell

Prior to joining Maze, she served as Head of Investor Relations and Corporate Communications at Merus NV, an oncology company developing bispecific antibodies, where she was responsible for leading investor relations, external communications and capital markets strategy and execution. Before her time at Merus, Jillian served as Head of Investor Relations for Wave Life Sciences, which focused on nucleic acid therapeutics for rare disease. Prior to Wave Life Sciences, Jillian was based in Boston as a consultant at The Trout Group LLC, an investor relations and corporate strategy consulting firm to private and public healthcare companies. For several years and prior to her work in healthcare investor relations, Jillian was an investment banker with Bank of America Merrill Lynch and UBS, Inc. in equity capital markets and institutional sales.

Jillian has held FINRA licenses for Series 7, 79 and 63 and holds a B.S. in International Relations from the University of Pennsylvania.